^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ABT-751

    i
    Associations
    News
    Trials
    Company:
    AbbVie, Eisai
    Drug class:
    Tubulin inhibitor, Vascular disrupting agent
    Related drugs:
    Associations
    News
    Trials